A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use
Citation
Price , D , Asukai , Y , Ananthapavan , J , Malcolm , B , Radwan , A & Keyzor , I 2013 , ' A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use ' , Applied Health Economics and Health Policy , vol. 11 , no. 3 , pp. 259-274 . https://doi.org/10.1007/s40258-013-0021-5